These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29678624)

  • 1. Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring.
    Francia P; Adduci C; Musumeci B; Semprini L; Palano F; Zezza L; Volpe M; Autore C
    Rev Port Cardiol (Engl Ed); 2018 Apr; 37(4):351.e1-351.e4. PubMed ID: 29678624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
    Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmias and Hypertrophic Cardiomyopathy: Unravelling the Connection.
    Aggarwal K; Boyapati SP; Valecha J; Noor A; Kanwal F; Jain R; Kanagala SG
    Curr Cardiol Rev; 2024; 20(4):39-48. PubMed ID: 38279754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.
    Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M
    Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular evaluation of pregnant women with hypertrophic cardiomyopathy.
    Güner A; Candan Ö; Kahraman S; Güner EG; Özcan S; Gürsoy MO; Kalçık M; Uslu A; Dönmez E; Zehir R; Ertürk M; Yıldız M; Özkan M
    Herz; 2023 Mar; 48(2):141-151. PubMed ID: 35364724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of cardiovascular magnetic resonance imaging for life-threatening arrhythmia detected by implantable cardioverter-defibrillator in Japanese patients with hypertrophic cardiomyopathy.
    Hen Y; Tsugu-Yagawa M; Iguchi N; Utanohara Y; Takada K; Machida H; Takara A; Teraoka K; Inoue K; Takamisawa I; Takayama M; Yoshikawa T
    Heart Vessels; 2018 Jan; 33(1):49-57. PubMed ID: 28766047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcome of hypertrophic obstructive cardiomyopathy in pregnant women: a case report.
    Assamti M; Bougrine R; Ismaili N; Ouafi NE
    Pan Afr Med J; 2021; 38():140. PubMed ID: 33912310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
    J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy.
    Mirelis JG; Sánchez-González J; Zorio E; Ripoll-Vera T; Salguero-Bodes R; Filgueiras-Rama D; González-López E; Gallego-Delgado M; Fernández-Jiménez R; Soleto MJ; Núñez J; Pizarro G; Sanz J; Fuster V; García-Pavía P; Ibáñez B
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):933-940. PubMed ID: 28341414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy.
    O'Mahony C; Lambiase PD; Rahman SM; Cardona M; Calcagnino M; Quarta G; Tsovolas K; Al-Shaikh S; McKenna W; Elliott P
    Europace; 2012 May; 14(5):724-33. PubMed ID: 22094454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic association of ventricular arrhythmia in non-ischaemic heart failure patients: results from the DANISH trial.
    Boas R; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Dixen U
    Europace; 2021 Apr; 23(4):587-595. PubMed ID: 33257933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study.
    Balaji S; DiLorenzo MP; Fish FA; Etheridge SP; Aziz PF; Russell MW; Tisma S; Pflaumer A; Sreeram N; Kubus P; Law IH; Kantoch MJ; Kertesz NJ; Strieper M; Erickson CC; Moore JP; Nakano SJ; Singh HR; Chang P; Cohen M; Fournier A; Ilina MV; Smith RT; Zimmerman F; Horndasch M; Li W; Batra A; Liberman L; Hamilton R; Janson CM; Sanatani S; Zeltser I; McDaniel G; Blaufox AD; Garnreiter JM; Katcoff H; Shah M
    Heart Rhythm; 2019 Oct; 16(10):1462-1467. PubMed ID: 31026510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy.
    Vijapurapu R; Bradlow W; Leyva F; Moon JC; Zegard A; Lewis N; Kotecha D; Jovanovic A; Hughes DA; Woolfson P; Steeds RP; Geberhiwot T
    Orphanet J Rare Dis; 2022 Jan; 17(1):6. PubMed ID: 34991670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Hodes AR; Tichnell C; Te Riele AS; Murray B; Groeneweg JA; Sawant AC; Russell SD; van Spaendonck-Zwarts KY; van den Berg MP; Wilde AA; Tandri H; Judge DP; Hauer RN; Calkins H; van Tintelen JP; James CA
    Heart; 2016 Feb; 102(4):303-12. PubMed ID: 26719359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator in pregnant women with hypertrophic cardiomyopathy.
    Paula LJ; Ribeiro HB; Oliveira Júnior RM; Silva KR
    Rev Bras Cir Cardiovasc; 2010; 25(3):406-9. PubMed ID: 21103751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.